Medica Sur SA de CV

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: MXP510121215
MXN
59.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,194.69
1,222.69
1,179.97
1,181.30
1,204.93
1,131.78
1,117.44
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,194.69
1,222.69
1,179.97
1,181.30
1,204.93
1,131.78
1,117.44
Raw Material Cost
769.59
782.41
769.16
746.83
774.35
750.82
745.48
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
25.41
27.20
41.02
19.10
18.88
18.93
18.96
Selling and Distribution Expenses
233.37
239.53
230.02
237.60
228.53
201.50
230.56
Other Expenses
-2.54
-2.72
-4.10
-1.91
-1.89
-1.89
-1.90
Total Expenditure (Excl Depreciation)
1,002.97
1,021.95
999.18
984.44
1,002.87
952.32
976.04
Operating Profit (PBDIT) excl Other Income
191.70000000000002
200.7
180.79999999999998
196.9
202.10000000000002
179.5
141.4
Other Income
24.21
40.82
41.54
19.62
25.40
29.34
47.25
Operating Profit (PBDIT)
266.42
292.24
270.45
267.50
277.70
259.26
239.62
Interest
25.41
27.20
41.02
19.10
18.88
18.93
18.96
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
425.10
440.27
410.81
434.47
430.59
380.96
371.95
Depreciation
50.49
50.68
48.12
51.01
50.24
50.46
50.97
Profit Before Tax
190.52
214.36
181.31
197.39
208.58
189.88
169.69
Tax
56.01
75.84
57.78
61.53
66.23
54.91
47.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
134.51
138.52
123.53
135.85
142.35
134.97
122.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
134.51
138.52
123.53
135.85
142.35
134.97
122.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
134.51
138.52
123.53
135.85
142.35
134.97
122.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,656.24
2,521.73
2,561.53
2,465.60
2,485.39
2,343.04
2,221.49
Earnings per share (EPS)
1.77
1.75
1.56
1.7
1.78
1.69
1.52
Diluted Earnings per share
1.77
1.75
1.56
1.7
1.78
1.69
1.52
Operating Profit Margin (Excl OI)
16.05%
16.42%
15.32%
16.67%
16.77%
15.86%
12.65%
Gross Profit Margin
20.17%
21.68%
19.44%
21.03%
21.48%
21.23%
19.75%
PAT Margin
11.26%
11.33%
10.47%
11.5%
11.81%
11.93%
10.93%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -2.29% vs 3.62% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -2.89% vs 12.15% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -3.66% vs 9.83% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -6.62% vs -33.66% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Medica Sur SA de CV With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(MXN)
Change(%)
Net Sales
1,194.69
0
1,194.69
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,194.69
0
1,194.69
Raw Material Cost
769.59
0
769.59
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
25.41
0
25.41
Selling and Distribution Expenses
233.37
0
233.37
Other Expenses
-2.54
0.00
-2.54
Total Expenditure (Excl Depreciation)
1,002.97
0
1,002.97
Operating Profit (PBDIT) excl Other Income
191.72
0.00
191.72
Other Income
24.21
0
24.21
Operating Profit (PBDIT)
266.42
0
266.42
Interest
25.41
0
25.41
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
425.10
0
425.10
Depreciation
50.49
0
50.49
Profit Before Tax
190.52
0
190.52
Tax
56.01
0
56.01
Provisions and contingencies
0
0
0.00
Profit After Tax
134.51
0
134.51
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
134.51
0
134.51
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
134.51
0
134.51
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
2,656.24
0
2,656.24
Earnings per share (EPS)
1.77
0
1.77
Diluted Earnings per share
1.77
0
1.77
Operating Profit Margin (Excl OI)
16.05%
0%
0.00
16.05%
Gross Profit Margin
20.17%
0%
0.00
20.17%
PAT Margin
11.26%
0%
0.00
11.26%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 119.47 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.29% vs 3.62% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -0.85% vs 11.60% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 13.45 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.89% vs 12.15% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -5.48% vs 16.74% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.22 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -3.66% vs 9.83% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -4.00% vs 15.42% in Mar 2025

Quarterly - Interest
Interest 2.54 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -6.62% vs -33.66% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 34.39% vs 1.61% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.05%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025